Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of mutations in circulating cell‐free DNA in relation to disease stage in colorectal cancer

27 May 2019

Abstract excerpt

Enthusiasm has emerged for the potential of liquid biopsies to provide easily accessible genetic biomarkers for early diagnosis and mutational cancer characterization. We here systematically investigated the suitability of circulating cell-free DNA (cfDNA) analysis for mutation detection in colorectal cancer (CRC) patients with respect to clinicopathological disease stage. Droplet Digital PCR (ddPCR) was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31134762
DOI: 10.1002/cam4.2219

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of mutations in circulating cell‐free DNA in relation to disease stage in colorectal cancerPMID 31134762Read ↗

KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.Semantic proximity Read ↗

Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients.Semantic proximity Read ↗

An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.Semantic proximity Read ↗

Detection of KRAS, NRAS and BRAF Mutations in Liquid Biopsy from Patients with Colorectal Cancer.Semantic proximity Read ↗

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.Semantic proximity Read ↗

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneitySemantic proximity Read ↗

Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR.Semantic proximity Read ↗

Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.Semantic proximity Read ↗

Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.Semantic proximity Read ↗

Detection of <i>KRAS, NRAS</i> and <i>BRAF</i> mutations in liquid biopsy from patients with colorectal cancerSemantic proximity Read ↗

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation SequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.